1.A Case of Steatocystoma Multiplex Developed on the Labium Major.
Moo Yeol HYUN ; Sun Young CHOI ; Kui Young PARK ; Kapsok LI ; Beom Joon KIM ; Seong Jun SEO ; Myeung Nam KIM ; Chang Kwun HONG
Korean Journal of Dermatology 2013;51(7):572-573
No abstract available.
Steatocystoma Multiplex
2.Fixed Drug Eruption Caused by Levocetirizine.
Moo Yeol HYUN ; Yeon A NO ; In Kwon YEO ; Kui Young PARK ; Kapsok LI ; Beom Joon KIM ; Seong Jun SEO ; Myeung Nam KIM ; Chang Kwun HONG
Korean Journal of Dermatology 2014;52(5):364-365
No abstract available.
Drug Eruptions*
3.Candida Esophagitis in a Patient with Cowden's Syndrome: A Case Report.
Kyung Ji KANG ; Hye Jung YUN ; Seong Yeol RYU ; Nam Hee RYOO ; Yu Na KANG ; Jin Bok HWANG
Korean Journal of Pediatric Gastroenterology and Nutrition 2009;12(1):46-50
Cowden's syndrome is a harmatomatous polyposis syndrome with characteristic mucocutaneous lesions and among the spectra of clinical disorders that has been attributed to germline mutations in the PTEN gene. Although Cowden's syndrome has rarely been reported, immunologic studies have revealed that patients with this syndrome have humoral and/or cellular immune abnormalities. We recently identified a 21-year-old woman with Cowden's syndrome who was diagnosed with candida esophagitis without a history of diabetes, carcinoma, or steroid therapy. We report the immunologic status of this patient and the relationship with candida esophagitis on the basis of a literature review.
Candida
;
Esophagitis
;
Female
;
Germ-Line Mutation
;
Hamartoma Syndrome, Multiple
;
Humans
;
Young Adult
4.Proliferating Trichilemmal Tumor with Primary Essential Cutis Verticis Gyrata.
In Kwon YEO ; Won Jong OH ; Moo Yeol HYUN ; Kui young PARK ; Kapsok LI ; Beomjoon KIM ; Seong Jun SEO ; Myeung Nam KIM ; Chang Kwun HONG
Korean Journal of Dermatology 2014;52(7):515-517
No abstract available.
5.Difference in F-18 FDG Uptake According to the Patterns of CT-Based Diagnosed Pulmonary Lymphangitic Carcinomatosis in Patients with Lung Cancer.
Sungmin JUN ; Yong Ki KIM ; In Ju KIM ; Seong Jang KIM ; Hyun Yeol NAM ; Bum Soo KIM
Nuclear Medicine and Molecular Imaging 2008;42(4):292-300
PURPOSE: Our purpose was to evaluate F-18 FDG uptake in pulmonary lymphangitic carcinomatosis (PLC) according to CT findings and histology of lung cancer. Materials and METHODS: Thirty-three lung cancer patients with PLC were enrolled in this retrospective study. All the patients had a CT-based diagnosis of PLC. Chest CT findings of PLC were classified on the basis of involvement of axial interstitium. We categorized the involvement of axial interstitium as group 1, and the involvement of peripheral interstitium only as group 2. Visual and semiquantitative analyses by F-18 FDG PET/CT were performed in the PLC lesions. At first, we analyzed the F-18 FDG uptake in the PLC by visual assessment. If abnormal uptake was seen in the PLC, we drew regions of interest in the PLC lesions to obtain the maximum SUVs (maxSUVs). RESULTS: Of the 33 patients, 22 had abnormal F-18 FDG uptake in the visual assessment. There was no significant difference in the frequency of abnormal F-18 FDG uptake between group 1 and group 2 (p=0.17), although the frequency of group 1 tended to be higher than group 2 (15/19 (78.9%) in group 1, 7/14 (50.0%) in group 2). However, group 1 had a higher maxSUV than group 2 (p<0.01, group 1: 2.9+/-1.4, group 2: 1.5+/-0.6). There was no significant difference in the frequency of abnormal F-18 FDG uptake and maxSUV among the histology of the lung cancers. CONCLUSION: The involvement of axial interstitium in the PLC by lung cancer has a higher maxSUV than the involvement of only peripheral interstitium.
Carcinoma
;
Humans
;
Lung
;
Lung Diseases, Interstitial
;
Lung Neoplasms
;
Retrospective Studies
;
Thorax
6.Value of the Serum Thyroglobulin Level Alteration at the First High Dose Radioiodine Treatment in Patients with Differentiated Thyroid Carcinoma.
Hyun Yeol NAM ; In Joo KIM ; Yong Ki KIM ; Seong Jang KIM ; Sungmin JUN ; Bum Soo KIM
Nuclear Medicine and Molecular Imaging 2009;43(4):294-300
PURPOSE: The purpose of this study was to evaluate if short-term serum thyroglobulin (Tg) elevation after radioiodine administration can predict successful radioiodine remnant ablation (RRA) and whether comparable RRA effectiveness is exhibited between a group administered with recombinant human thyrotropin (rhTSH) and a group experiencing thyroid hormone withdrawal (THW), in preparation for RRA. MATERIALS AND METHODS: A retrospective chart review was performed on 39 patients in the rhTSH group and 46 patients in the THW group. They were treated for differentiated thyroid carcinoma by total or near total thyroidectomy, and referred for RRA between 2003 and 2006 (the rhTSH group) and between January and June of 2006 (the THW group). They were assessed for serum Tg levels just before I-131 administration (TgD0), reassessed 9 days later (TgD9), and again 6-12 months later. RESULTS: RRA was successful in 64 (37 from the THW group and 27 from the rhTSH group) of the total 85 patients. The success rates of RRA had no statistically significant differences between the two groups. In both groups, TgD9/TgD0 values were significantly higher in the RRA success group (the rhTSH group; P=0.03, the THW group; P=0.04). By combining cutoff values of TgD0 and TgD9/TgD0, the successful RRA value was determined to be 96.7% (29/30) with TgD0< or =5.28 ng/mL and TgD9/TgD0>4.37 in both groups (the rhTSH group; 100% (16/16), the THW group; 92.9% (13/14)). Using logistic multivariate analysis, only TgD0 was independently associated with successful RRA. CONCLUSION: We may predict successful ablation by evaluating short-term serum Tg elevation after I-131 administration for RRA, in both rhTSH and THW patients.
Humans
;
Multivariate Analysis
;
Retrospective Studies
;
Thyroglobulin
;
Thyroid Gland
;
Thyroid Neoplasms
;
Thyroidectomy
;
Thyrotropin
;
Thyrotropin Alfa
7.Meningitis following vaccination with yellow-fever vaccine.
Seong Yeol RYU ; Young Ran JU ; Young Eui JEONG ; Myung Guk HAN ; Nam Hi RYOO
Korean Journal of Medicine 2009;76(Suppl 1):S204-S207
Yellow fever is the original viral hemorrhagic fever (VHF), a pansystemic viral sepsis with viremia, fever, prostration, hepatic, renal, and myocardial injury, hemorrhage, shock, and high lethality. Yellow fever was one of the most feared lethal diseases before the development of an effective vaccine. Yellow fever (YF) can be prevented by an attenuated vaccine. The yellow-fever 17D vaccine developed in the 1930s has been regarded as one of the most successful live attenuated vaccines, with few side effects or adverse events. The adverse effects associated with yellow-fever vaccine are generally mild and include headache, myalgia, and low-grade fever. Recently, however, some cases of severe neurologic disease and multi-organ system disease have been described in individuals who received yellow-fever vaccine. We report the case of a 39-year-old female with meningitis following vaccination with 17D yellow-fever vaccine.
Adult
;
Female
;
Fever
;
Headache
;
Hemorrhage
;
Hemorrhagic Fevers, Viral
;
Humans
;
Meningitis
;
Sepsis
;
Shock
;
Vaccination
;
Vaccines, Attenuated
;
Viremia
;
Yellow Fever
8.Mold Occurring on the Air Cleaner High-Efficiency Particulate Air Filters Used in the Houses of Child Patients with Atopic Dermatitis.
Seong Hwan KIM ; Geum Ran AHN ; Seung Yeol SON ; Gwi Nam BAE ; Yeo Hong YUN
Mycobiology 2014;42(3):286-290
Fungi are the known sources of irritation associated with atopic diseases (e.g., asthma, allergic rhinoconjunctivitis, and atopic eczema). To quantitatively estimate their presence in the indoor environment of atopic dermatitis-inflicted child patient's houses (ADCPHs), the high-efficiency particulate air (HEPA) filters installed inside the air cleaners of three different ADCPHs were investigated for the presence of mold. The air cleaner HEPA filters obtained from the three different ADCPHs were coded as HEPA-A, -B, and -C, respectively, and tested for the presence of mold. The colony forming units (CFUs) corresponding to the HEPA-A, -B, and -C filters were estimated to be 6.51 x 10(2) +/- 1.50 x 10(2) CFU/cm2, 8.72 x 10(2) +/- 1.69 x 10(2) CFU/cm2, and 9.71 x 10(2) +/- 1.35 x 10(2) CFU/cm2, respectively. Aspergillus, Penicillium, Alternaria, Cladosporium, Trichoderma, and other fungal groups were detected in the 2,494 isolates. The distribution of these fungal groups differed among the three filters. Cladosporium was the major fungal group in filters HEPA-A and -C, whereas Penicillium was the major fungal group in the filter HEPA-B. Nine fungal species, including some of the known allergenic species, were identified in these isolates. Cladosporium cladosporioides was the most common mold among all the three filters. This is the first report on the presence of fungi in the air cleaner HEPA filters from ADCPHs in Korea.
Air Filters*
;
Alternaria
;
Aspergillus
;
Asthma
;
Child*
;
Cladosporium
;
Dermatitis, Atopic*
;
Fungi*
;
Humans
;
Korea
;
Penicillium
;
Stem Cells
;
Trichoderma
9.A Case of Inflammatory Myofibroblastic Tumor of the Maxillary Sinus.
Nam Yong DO ; Jun Han LEE ; Seong Yeol KIM
Korean Journal of Otolaryngology - Head and Neck Surgery 2005;48(3):418-422
Inflammatory myofibroblastic tumor (inflammatory pseudotumor) is a term used to describe the space occupying the neoplastic lesion rather than the inflammatory lesion. Its occurrence in the maxillary sinus is rare. The etiology and pathophysiology of the maxillary inflammatory myofibroblastic tumor is unknown. The diagnosis must be based on histological evidence to exclude other disease. We report a case of a 72-year-old patient with maxillary and nasal cavity inflammatory myofibroblastic tumor that simulated an invasive neoplasm in its clinical presentation, Radiologic findings showed near total coagulation necrosis histopathologically.
Aged
;
Diagnosis
;
Granuloma, Plasma Cell
;
Humans
;
Maxillary Sinus*
;
Myofibroblasts*
;
Nasal Cavity
;
Necrosis
10.Phase II Study of Concurrent Chemotherapy with Etoposide and Cisplatin (EP) and Radiation Therapy for Unresectable Stage III Non-small Cell Lung Cancer.
Nam Hyun HUR ; Choon Taek LEE ; Jae Hag KIM ; Seung Mo NAM ; Yeon Hee PARK ; Baek Yeol RYOO ; Tae You KIM ; Young Hyuck IM ; Yoon Koo KANG ; Mi Sook KIM ; Seong Yul YOO ; Jhin Oh LEE ; Tae Woong KANG
Tuberculosis and Respiratory Diseases 1997;44(4):776-784
BACKGROUND: Various combinations of treatment modalities have been reported in stage III non-small cell lung cancer (NSCLC), however, the standard treatment modality has not established yet. Recently, the efficacy of concurrent chemotherapy and radiation therapy has been reported in locally advanced lung cancer. We evaluate the response rate, toxicity, arid survival of concurrent chemotherapy with etoposide and cisplatin(EP) arid radiation therapy for unresectable stage III NSCLC. METHODS: Between October 1995 and December 1996, 32 patients with histologically proven unresectable stage III NSCLC without, malignant pleural effusion were entered into this study. Twenty-nine patients were eligible for the response, survival, and toxicity analysis. Induction was two cycles of chemotherapy with etoposide arid cisplatin plus concurrent chest RT to 4500cGy. Resection was attempted if the clinical response offered surgical resectability. Boost radiation therapy upto 5940cGy and one cycle of EP were performed if the disease were stable or responsive but still unresectable. RESULTS: Of 29 eligible patients, 22(75.9%) showed partial response(PR). The progression free interval was 6.3months(range 1.1 to 19.5months). Surgical resection was performed in one patient The median survival was l2.1months and one-year survival rate was 50.6%. The major toxicity was leukopenia(> or = grade 3,46%) Thrombocytopenia over grade 3 was found in 1%. Radiation pneumonitis occurred in 13 patients(46%). CONCLUSION: Concurrent chemotherapy(EP) pins radiotherapy was effective and tolerable in the treatment of unresectable stage III NSCLC.
Carcinoma, Non-Small-Cell Lung*
;
Cisplatin*
;
Drug Therapy*
;
Etoposide*
;
Humans
;
Lung Neoplasms
;
Pleural Effusion, Malignant
;
Radiation Pneumonitis
;
Radiotherapy
;
Survival Rate
;
Thorax
;
Thrombocytopenia